Bimatoprost for Angle-Closure Glaucoma
Author Information
Author(s): Vyas Prateep, Naik Uday, Gangaiah Jayasheel
Primary Institution: Choithram Netralaya, Indore, India
Hypothesis
Does bimatoprost 0.03% effectively lower intraocular pressure in patients with 360° synechial angle-closure glaucoma?
Conclusion
Bimatoprost 0.03% significantly reduces intraocular pressure in patients with 360° synechial angle-closure glaucoma.
Supporting Evidence
- The mean reduction in intraocular pressure was 15.3 ± 9.5 mmHg after 8 weeks of treatment.
- Conjunctival hyperemia was the most common side effect, occurring in 35% of patients.
- 85% of patients had unilateral angle-closure glaucoma.
Takeaway
This study found that a medicine called bimatoprost can help lower eye pressure in people with a specific type of glaucoma.
Methodology
This was a prospective, non-randomized, single-center pilot study involving 20 patients treated with bimatoprost for 8 weeks.
Limitations
The study had a small sample size and a short duration.
Participant Demographics
Participants were Indian patients aged 40 to 70 years, with a majority being female (65%).
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website